Показано 0 из 0
Дата |
---|
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
7.35
|
7.35
|
7.40
|
7.40
|
|
|
|
|
7.35
|
7.50
|
7.50
|
7.50
|
7.60
|
7.60
|
|
|
|
|
7.65
|
7.75
|
7.75
|
7.65
|
7.85
|
7.65
|
|
|
7 316.90
|
6.00
|
7.85
|
8.00
|
8.10
|
8.10
|
8.10
|
8.10
|
|
|
|
|
8.00
|
8.15
|
7.80
|
7.80
|
7.85
|
7.85
|
|
|
|
|
7.85
|
8.00
|
7.80
|
7.75
|
7.85
|
7.85
|
|
|
|
|
8.30
|
8.40
|
8.35
|
8.35
|
8.35
|
8.35
|
|
|
|
|
8.30
|
8.45
|
7.75
|
7.65
|
7.90
|
7.65
|
|
|
7 426.00
|
5.00
|
7.75
|
7.90
|
7.50
|
7.45
|
7.50
|
7.45
|
|
|
|
|
7.52
|
7.685
|
7.49
|
7.22
|
7.49
|
7.235
|
|
|
8 674.50
|
6.00
|
Outlook Therapeutics, Inc., formerly Oncobiologics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, manufacturing, and commercializing complex biosimilar therapeutics in immunology and oncology disease areas.